GetTopicDetailResponse(id=b67712628680, topicName=莫洛利單抗, introduction=, content=AML 阿扎胞苷 維奈托克 莫洛利單抗, image=null, comments=0, allHits=277, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Apr 23 14:31:00 CST 2025, time=2025-04-23, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503714, tagList=[TagDto(tagId=503714, tagName=莫洛利單抗)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2261711, encodeId=420c2261e1121, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a> <a href='/topic/show?id=1115e90262d' target=_blank style='color:#2F92EE;'>#維奈托克#</a> <a href='/topic/show?id=b67712628680' target=_blank style='color:#2F92EE;'>#莫洛利單抗#</a>, objectTitle=Blood | ENHANCE-3試驗：維奈托克和阿扎胞苷聯合莫洛利單抗或安慰劑治療不適合強化治療的急性髓系白血?。ˋML）, objectType=article, longId=872907, objectId=af6c8e290740, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240702/1719884874961_92910.jpg, objectUrl=/article/show_article.do?id=af6c8e290740, replyNumber=0, likeNumber=42, createdTime=2025-04-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af6c8e290740, moduleTitle=Blood | ENHANCE-3試驗：維奈托克和阿扎胞苷聯合莫洛利單抗或安慰劑治療不適合強化治療的急性髓系白血?。ˋML）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=af6c8e290740)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-23
